Navigation Links
Universal vaccination associated with decreased Canadian cases of most deadly strain of meningitis
Date:3/2/2009

Universal childhood vaccination against meningococcal C appears to reduce Canadian incidence of the most deadly strain of bacterial meningitis, reports new research published in the March issue of The Pediatric Infectious Disease Journal.

The Men C vaccine was introduced as part of universal immunization programs for children in Quebec and Alberta in 2002 and in British Columbia and Prince Edward Island in 2003.

By 2005, all Canadian provinces included Men C vaccine as part of routine childhood vaccinations. Staggered implementation across Canada offered researchers the opportunity to evaluate the universal vaccination program.

"There was a dramatic decline in provinces with the early immunization program, suggesting the program works," says Dr. Julie Bettinger, the study's lead author.

Dr. Bettinger is a scientist in the Vaccine Evaluation Centre at the Child & Family Research Institute and assistant professor in the Department of Pediatrics at the University of British Columbia.

Prior to Men C universal vaccination, BC, Alberta, and Quebec had rates of meningococcal C disease that were nearly 4.5 times higher than the rest of Canada. The study reports that today these provinces have the lowest rates in Canada, from 0.41 cases per 100,000 people in 2002 down to 0.07 per 100,000 in 2006. The provinces with later introduction of universal Men C vaccination showed no major changes in the one year of follow up study, with annual rates of meningococcal C at 0.08 per 100,000 people in 2006.

"The numbers may seem small, but even one case of the disease is one too many," says Dr. Bettinger. "It can strike without warning and cause death or permanent physical or neurological disability. Because meningococcal infection is spread by saliva through coughing, sneezing, and kissing, it has the potential to become an epidemic. Universal vaccination is critical to control disease and prevent epidemics."

Meningitis is an infection of the lining that covers the brain and spinal cord. It can be caused by viruses and bacteria. The viral causes of meningitis are rarely life-threatening whereas the bacterial types are more deadly. There are five strains of meningitis caused by the meningococcal bacteria (called serogroups A, B, C, Y, and W135). Meningococcal vaccines protect against A, C, Y, W135 with the Men C public vaccination programs targeting the meningococcal C bacteria. The researchers did not observe significant changes in the rates of other strains causing meningitis following introduction of the meningococcal C vaccination program.

Infection with the meningococcal bacteria develops suddenly into a medical emergency that must be treated in hospital with IV antibiotics. Initial symptoms include fever, headache, stiff neck, vomiting, and drowsiness while in infants it may show as irritability and lethargy. It can cause gangrene leading to amputation of limbs, blindness, deafness, brain damage, and cognitive and neurological disability. Children, adolescents, and immuno-compromised individuals are most vulnerable to infection.

Meningococcal C is the most fatal strain of bacterial meningitis. It infects approximately 250 Canadian children and adults each year, according to the BC Centre for Disease Control. For every 100 children who get sick, up to 15 will die. Those who survive may face life-long disability.

The Men C vaccine is provided free to all children in BC along with the regular childhood vaccinations. Infants need two doses: one needle at two months of age and then another at 12 months. The vaccine is also provided to people who may be vulnerable because they are missing a spleen, they have a weak immune system, are transplant recipients, or they have a cochlear (inner ear) implant.

The Men C vaccine is the first product suitable for infants offering long-term immunity against meningococcal C and it became commercially available in 2001. Previously, adolescents or adults received a different vaccine which provided protection for about three years.

For the study, the 12 pediatric centres involved with the Canadian Immunization Monitoring Program, Active (IMPACT), carried out surveillance in collaboration with local public health officials. IMPACT meningococcal surveillance is administered by the Canadian Paediatric Society and funded by Sanofi Pasteur. Its surveillance centres are located in Newfoundland, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, and BC.

"What's needed next is a vaccine against meningococcal B," says Dr. Bettinger. "This is the Holy Grail of vaccine research."


'/>"/>

Contact: Jennifer Kohm
jkohm@cw.bc.ca
604-875-2401
Child & Family Research Institute
Source:Eurekalert

Related medicine news :

1. Universal Health Realty Income Trust Reports 2008 Fourth Quarter and Full Year Financial Results
2. CWA Commends Obama Administration Steps Toward Universal Health Care
3. Universal Health Services, Inc. Reports Significant Increases in 2008 Fourth Quarter and Full Year Earnings from Continuing Operations Per Diluted Share and Reports 2009 Guidance
4. Universal Health Services, Inc. Announces Dividend
5. Does universal health care affect attitude toward dementia?
6. Universal Benefit Plans and Universal Dental Plan Announce Joint Outreach Initiative to Aid Massachusetts Nonprofits
7. Universal Music Enterprises (UMe) and Body By Jake Global Create the Worlds First Digital Fitness Music Label
8. UT public health policy expert says US can learn from Dutch universal health-care coverage
9. UT public health policy expert says US can learn from Dutch universal healthcare coverage
10. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
11. Universal American Announces New Patient Care Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... Many individuals looking to lead a healthy lifestyle have ... IsoPasta by Isolator Fitness has delved into this niche allowing those giving up ... repercussions. IsoPasta has 30 grams of protein and only 7 grams of carbohydrates ...
(Date:2/13/2016)... ... February 13, 2016 , ... ... Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... learn how to start an IV and draw blood, combining technology with traditional ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... According to ... surgeries are beginning to account for a significant portion of hernia repairs throughout the ... of the Beverly Hills Hernia Center notes that this trend has not only been ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... ... February 12, 2016 , ... As a former television ... a demanding job, and no time to decompress, Rabinowitz found herself drawn to a ... meditation for its impact on her life, implementing a 20-minute-per-day meditation practice with her ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Hypermarcas S.A. ("Hypermarcas") today announced that ... "Tender Offer") to purchase any and all of ... its 6.500% Senior Notes due 2021 (CUSIP Nos. ... "Notes"). In connection with the Tender Offer, Hypermarcas ... "Consents") of the holders of the Notes (the ...
(Date:2/12/2016)... Feb. 12, 2016   HeartWare International, Inc . ... and webcast to discuss its financial results for the ... Thursday, February 25, 2016 at 8:00 a.m. ET.  The ... the conference call and webcast.  On the conference call ... highlights from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... -- On Thursday, Feb. 11, 2016, surgeons at the ... Austin Medical Center successfully completed the first robotic surgery ... Surgical System with Trumpf Medical,s advanced operating table, the ... M.D., colorectal surgeon at the Texas Institute for Robotic ... technology, which seamlessly combines the da Vinci Xi Surgical ...
Breaking Medicine Technology: